Cat Chronic Hepatitis: Welfare and Long-Term Management

Chronic hepatitis and inflammatory liver disease in cats causes progressive hepatic dysfunction with welfare implications that require ongoing management and monitoring to maintain quality of life.

Key Facts

Chronic inflammatory liver disease in cats includes cholangitis, lymphocytic cholangitis, and hepatic lipidosis
Hepatic lipidosis (fatty liver) develops rapidly in anorexic cats and is life-threatening without aggressive nutritional support
Inflammatory liver disease is often associated with concurrent inflammatory bowel disease and pancreatitis (triaditis)
Clinical signs include weight loss, vomiting, jaundice, lethargy, and reduced appetite
Liver biopsy is required for definitive diagnosis and guides treatment selection
Long-term management includes immunosuppressive therapy, ursodeoxycholic acid, and nutritional support

Welfare Considerations

Chronic liver disease in cats imposes sustained welfare costs through nausea, reduced appetite, and progressive decline in hepatic function. Hepatic lipidosis represents an acute welfare emergency in anorexic cats that escalates rapidly without intervention. Cats with triaditis face a complex multi-organ management challenge. Long-term immunosuppressive therapy requires regular monitoring and can have side effects. With appropriate diagnosis and management, many cats with chronic hepatitis maintain acceptable quality of life over extended periods.

What You Can Do

Seek veterinary assessment promptly for any cat showing prolonged inappetence, vomiting, or jaundice
Never allow an overweight cat to go without eating for more than 24-48 hours due to hepatic lipidosis risk
Place feeding tubes in cats that cannot maintain voluntary food intake during hepatic lipidosis treatment
Discuss liver biopsy with your vet to obtain a specific diagnosis guiding appropriate treatment
Monitor liver values regularly during long-term treatment to detect disease progression or treatment side effects